were approached about
participation by the site investigator and
nurse coordinator. Patients were considered
eligible for enrollment in the
study if they had symptomatic coronary
artery disease with objective evidence
of ischemia (eg, symptoms of angina
pectoris, positive stress test results,
or dynamic electrocardiographic [ECG]
changes); were referred for PCI, or
thought to be at high likelihood for
requiring PCI with either stent placement
with or without conventional balloon
angioplasty or another revascularization
device; were at least 21 years old;
provided informed consent before randomization;
and agreed to comply with
all protocol-specified procedures.